Results 131 to 140 of about 840,241 (310)

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

A Discussion on the Bakhtin Circle

open access: yes, 2017
Paromita Chakrabarti and Yulia Gradskova discuss the Bakhtin Circle with five experts in the field: Caryl Emerson, university professor emeritus of Slavic languages and literatures, Princeton University; Lakshmi Bandlamudi, professor of psychology at ...
Tihanov, G.   +6 more
core  

Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis

open access: yesMolecular Oncology, EarlyView.
This schematic outlines the workflow from biomarker identification to duplex MethyLight assay validation for epithelial ovarian cancer diagnosis using cfDNA‐based liquid biopsy. Initial screening of hypermethylated CpG candidates (cg02957270, cg10061138 cg00480298, COL2A1) was performed in tissue using ARMS‐PCR, COBRA, qPCR and image analysis. Selected
Deepa Bisht   +3 more
wiley   +1 more source

Chautauqua Circle Members, circa 1988

open access: yes
Members pose for a group photograph at the Chautauqua Circle 75th anniversary ...

core  

CIRCLE project final report

open access: yes, 2009
The final report for the JISC funded CIRCLE project. The CIRCLE project, funded by the JISC under the Repositories and Preservation programme, looked at the development of a "blended" repository of learning objects and research outputs using Intralibrary
Haines, Jan   +4 more
core  

Circles

open access: yesAcademic Pediatrics
Victoria Mok Siu, Jennifer Michelle Siu
openaire   +4 more sources

Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution

open access: yesMolecular Oncology, EarlyView.
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski   +12 more
wiley   +1 more source

Juha Manninen and Friedrich Stadtler (eds.), The Vienna Circle and the Nordic Countries. Networks and Transformations of Logical Empiricism (Vienna: Vienna Circle Institute Yearbook vol.14, Springer, 2010)

open access: yes, 2013
A discussion of The Vienna Circle and the Nordic Countries. Networks and Transformations of Logical Empiricism, edited by Juha Manninen and Friedrich Stadtler, Vienna Circle Institute Yearbook vol.14, Springer ...
Carlo Penco, Penco, Carlo, 1948-
core  

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy